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Acute hypoxemia due to lung collapse in COVID-19: 
the role of therapeutic bronchoscopy
Abstract
Bronchoscopy is an aerosol-generating procedure and involves a high risk of transmission of SARS-CoV-2 to health care workers. 
There are very few indications for performing bronchoscopy in a patient with confirmed COVID-19. These include atelectasis, for-
eign body aspiration, and suspected superinfection in immunocompromised patients. Proper use of standard personal protective 
equipment is mandatory to reduce the risk of transmission to health care workers. In this article, we describe a case of acute 
lung collapse in a 16-year-old boy with cerebral palsy who was infected with COVID-19. This patient responded to therapeutic 
bronchoscopy and had complete resolution of lung collapse within 24 hours of the procedure. 
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Introduction
Therapeutic bronchoscopy is frequently 
used in the intensive care unit (ICU) due to 
lobar atelectasis that is unresponsive to chest 
physiotherapy [1]. It is an aerosol-generating 
procedure that has a high risk of transmission of 
coronavirus disease 2019 (COVID-19) to health 
care workers (HCWs). Specific guidelines have 
been introduced for performing bronchoscopy 
during the time of the COVID-19 pandemic, and 
these guidelines include instructions on the use 
of adequate personal protective equipment (PPE) 
[2–5]. Bronchoscopy in confirmed COVID-19 pa-
tients is indicated in conditions such as lung 
collapse due to mucus plugging or foreign body 
aspiration, suspected superinfections in immuno-
compromised patients, management of massive 
hemoptysis (in conjunction with other measures), 
central airway obstruction, bronchoscopic in-
tubation, and percutaneous tracheostomy [3]. 
However, the role of bronchoscopy is limited in 
the diagnosis of COVID-19 due to the substantial 
risk of transmission of the disease to health care 
workers, and because of the availability of low-
risk and non-invasive upper respiratory samples 
obtained from oropharyngeal and nasopharyngeal 
swabs. Here, we present a case of a young male 
who presented with acute worsening hypoxemia 
and left lung collapse with a history of contact 
with a confirmed COVID-19 patient who was 
managed with therapeutic bronchoscopy.
Case presentation
A 16-year-old boy presented to the emer-
gency department with a history of progressive 
shortness of breath for three days. There was 
a doubtful history of aspiration of a piece of a toy 
(in the form of a wool ball) three days ago during 
an episode of a seizure. There was no history of 
upper respiratory symptoms or fever. The patient 
was previously diagnosed with cerebral palsy 
with spastic diplegia, and also had a seizure 
disorder. He had been bedridden for three years 
and was dependant for all activities of daily liv-
ing. His mother was the primary caretaker and 
was detected to be COVID-19 positive about two 
weeks back, but was asymptomatic. On examina-
tion, he had tachypnea with a respiratory rate of 
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30 per minute, and a saturation of 95% on oxygen 
inhalation at 8 L/min with a facemask. He was 
hemodynamically stable. His nasopharyngeal and 
oropharyngeal swabs were sent for COVID-19 RT-
PCR and came back positive. Chest X-ray demon-
strated left lung collapse with scoliosis (Figure 
1A). A contrast-enhanced computed tomography 
was ordered because of the suspicion for foreign 
body aspiration. It revealed an oval, smooth le-
sion in the distal left main bronchus which was 
suspicious for a foreign body or mucous plugging. 
There was also evidence of a collapsed left up-
per and lower lobe. There was a gross scoliotic 
deformity with convexity towards the right and 
a resultant deviation of the mediastinum and 
vascular structures to the left hemithorax. He was 
transferred to the ICU as a result of an increased 
need for oxygen. Due to worsening hypoxemia, 
a decision to begin therapeutic bronchoscopy was 
undertaken. For the procedure, all the necessary 
equipment and materials were prepared outside 
the COVID-19 ICU. This included saline, syringes, 
and the bronchoscopy system (therapeutic bron-
choscope with a monitor). A negative pressure 
room was not available for the procedure. As per 
recommendations, all PPE were used. These in-
cluded an N95 mask, goggles, two sets of gloves, 
and a plastic protective gown which included 
a head and neck cover. Flexible bronchoscopy was 
performed via the oral route under sedation. The 
sedative agents used included propofol and fen-
tanyl. Topical anesthesia via oropharyngeal spray 
and the ‘bronchoscopic spray as you go’ method 
were provided using 2% lidocaine. The left main 
bronchus showed a large thick mucus plug which 
was removed with thorough suctioning follow-
ing saline instillation. No foreign body could be 
identified. Following the procedure, the patient 
required intubation due to worsening hypoxia. 
A chest X-ray performed 24-hours following the 
procedure showed complete expansion of the left 
lung (Figure 1B). He was further managed using 
standard COVID-19 care protocols which includ-
ed administration of steroids and hydroxychlo-
roquine. He was subsequently extubated on day 
three of admission and was discharged home on 
day 12 with a room air oxygen saturation of 97%.
Discussion
This case describes the therapeutic role 
of bronchoscopy in a patient with confirmed 
COVID-19. The use of therapeutic bronchoscopy 
in this patient facilitated his recovery from acute 
hypoxemic respiratory failure.
Across numerous studies, flexible bronchos-
copy has been shown to be effective in removing 
secretions and improving atelectasis with success 
rates between 79–89% [6]. Lobar atelectasis re-
sponds better than subsegmental atelectasis. This 
is likely due to the larger size of mucus plugs 
which are amenable for bronchoscopic removal. 
Figure 1. A. The chest radiograph demonstrating scoliosis with complete opacification of the left hemithorax with a mediastinal shift to the same 
side suggesting left lung collapse; B. The chest radiograph following bronchoscopy demonstrating complete clearance of the left lung with aeration
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Other modalities for the treatment of atelectasis 
(i.e. chest physiotherapy) are also useful in the 
majority of individuals. A randomized controlled 
trial studying the use of an aggressive chest phys-
iotherapy regimen versus the use of bronchoalve-
olar lavage for the treatment of acute atelectasis 
showed the same extent of improvement at 24 and 
48 hours in terms of the radiological resolution of 
the atelectasis [6]. Patients with restrictive lung 
diseases, such as neuromuscular diseases, are 
more prone to develop atelectasis due to mucous 
plugging. If these patients develop pneumonia, 
lobar or complete collapse of the lung can oc-
cur. In such conditions, bronchoscopy remains 
the procedure of choice for its diagnostic and 
therapeutic value. This was affirmatively the 
case in our patient as there was suspicion of an 
aspirated foreign body and an inability to coop-
erate with aggressive chest physiotherapy due 
to his severe hypoxia and his comorbid cerebral 
palsy. As a result, we decided to treat the patient 
with therapeutic bronchoscopy. Bronchoscopy, 
in critically ill patients, is not without risk. The 
overall incidence of complications and mortality 
during fiberoptic bronchoscopy based on a large 
prospective study covering 19 Italian centres 
encompassing 20,986 bronchoscopies was ap-
proximately between 0.02% and 1.1% [7]. The 
most common complications of bronchoscopy are 
bronchospasm, hypoxemia, cardiac arrhythmias, 
hypotension, bleeding and hemoptysis, pneumo-
thorax, myocardial infarction/pulmonary edema, 
and death [8]. Our patient also needed intubation 
in the post-procedural period due to hypoxia. His 
oxygen requirement prior to the procedure was 
high. We initially planned to electively intubate 
him before bronchoscopy. However, keeping in 
mind the poor prognosis of COVID-19 patients 
on invasive mechanical ventilation, and after 
discussion with family members, a decision for 
proceeding with bronchoscopy was made. 
A previous study described 101 bronchos-
copies in 93 patients with COVID-19 on invasive 
mechanical ventilation with the major indica-
tion being superinfection (63/101), followed by 
airway secretion management with or without 
atelectasis (38/101) [9]. Ninety-five per cent 
of the patients showed thick white gelatinous 
secretions that were difficult to suction. This 
could be the result of either direct viral effect or 
because of heat moisture exchanger use among 
ventilated patients. One bronchoscopist out of 
the three performing the procedure was infect-
ed, but it is unclear whether the infection was 
procedure-related. In our patient, none of the 
healthcare workers involved in bronchoscopy 
were diagnosed with COVID-19 during the four 
week period following bronchoscopy.
Conclusion
In cases with definitive indications, thera-
peutic bronchoscopy should not be delayed in 
COVID-19 confirmed cases as the procedure may 
be lifesaving. Proper use of PPE helps in reducing 
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